Market Synopsis of the Global Dysfunctional Uterine Bleeding Market
Dysfunctional uterine bleeding, also known as abnormal uterine bleeding, is irregular bleeding occurring in the absence of any recognizable pelvic pathology. Pregnancy is a common cause of abnormal uterine bleeding. The main causes of uterine bleeding can be fibroids in the uterus, infection of the cervix, and cancer of the uterus in some cases. Medications causing dysfunctional uterine bleeding are birth control pills, hormonal agents, and Coumadin.
Rising prevalence of uterine disorders such as uterine cancer, polycystic ovary syndrome, endometriosis, and uterine polyps drive the market growth. Furthermore, rising prevalence of uterine cancer, and demand for diagnosis and treatment measures also influence the market growth. According to the Cancer Research, in 2014, 9324 new cases of uterine cancer were diagnosed in U.K and the number is expected to increase in the near future.
According to the World Cancer Research Fund International, endometrial cancer is the sixth most common cancer in women worldwide, with 320,000 new cases diagnosed in 2012. It also stated that about 53% of endometrial cancer cases occurred in the developed countries.
The global dysfunctional uterine bleeding market is expected to grow at a CAGR of 8.2% during the forecast period.
View Reports Sample @ https://www.marketresearchfuture.com/sample_request/4685
The global dysfunctional uterine bleeding market is segmented on the basis of type, diagnosis, treatment, and end user.
On the basis of type, market is segmented into ovulatory, and anovulatory.
On the basis of diagnosis, the market is segmented into hysteroscopy, ultrasonography, dilation and curettage, endometrial biopsy, and others.
On the basis of treatment, the market is segmented into pharmacologic treatment, hysterectomy, endometrial ablation, and others. The pharmacologic treatment includes oral contraceptives, estrogen, progestins, desmopressin and others.
On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, pharmaceutical companies, and others.
Regional Analysis of the Global Dysfunctional Uterine Bleeding Market
America is the largest market for dysfunctional uterine bleeding market across the globe. The market is driven by the rising prevalence of uterine cancer and other uterine disorders among women. According to the American Cancer Institute, about 61,380 new cases of uterine cancer is estimated to be diagnosed in 2017.
Europe is the second largest market owing to an increasing demand for diagnosis and treatment measures for uterine cancer, fibroids and other disorders, and increasing emphasis on women healthcare.
The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing prevalence of menstrual disorders, rising awareness about causes of such disorders and early diagnosis and treatment measures among women. The market is also driven by rising prevalence of sexually transmitted diseases among women in the developing nations.
The Middle East & Africa also show a steady rise in the market owing to increasing focus on women and child health, and need of primary care services in developing regions.
Request Full Report @ https://www.marketresearchfuture.com/reports/dysfunctional-uterine-bleeding-market-4685
Key Players in the Global Dysfunctional Uterine Bleeding Market
Some of the key players in this market are B. Braun Melsungen AG (Germany), Hologic Inc. (U.S.), Karl Storz Gmbh & Co. KG (Germany), Medgyn Products, Inc., Olympus (Japan), Richard Wolf GmbH (Germany), Stryker (U.S.), Xion Medical GmbH (Germany), Cadila Pharmaceuticals Ltd. (India), Torrent Phamraceuticals (India).
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar